SOP for Preparing for Regulatory Inspections in Aerosol Manufacturing
| Department | Aerosol |
|---|---|
| SOP No. | SOP/Aerosol/165/2025 |
| Supersedes | SOP/Aerosol/165/2022 |
| Page No. | Page 1 of Y |
| Issue Date | 06/02/2025 |
| Effective Date | 16/02/2025 |
| Review Date | 06/02/2028 |
1. Purpose
The purpose of this Standard Operating Procedure (SOP) is to define a structured approach to preparing for regulatory inspections in aerosol manufacturing. Proper preparation ensures compliance with Good Manufacturing Practices (GMP) and other regulatory requirements, minimizes non-compliance risks, and facilitates a smooth inspection process.
2. Scope
This SOP applies to all personnel involved in regulatory inspections at the aerosol manufacturing facility, including Quality Assurance (QA), Production, Maintenance, and Regulatory Affairs. It covers activities before, during, and after inspections by regulatory agencies such as the FDA, EMA, and local drug control authorities.
3. Responsibilities
- Regulatory Affairs Team: Responsible for coordinating inspection activities, maintaining updated regulatory documentation, and serving as the primary contact for inspectors.
- Quality Assurance (QA) Team: Responsible for ensuring GMP compliance, conducting internal audits, and assisting with document retrieval during inspections.
- Production Team: Responsible for ensuring manufacturing processes comply with regulatory standards and assisting inspectors during plant walkthroughs.
- Maintenance Team: Responsible for ensuring equipment, utilities, and environmental conditions meet compliance standards.
- HR and Training Team: Responsible for maintaining training records of employees and ensuring staff is well-prepared for
inspections.
4. Accountability
The Regulatory Affairs Manager is accountable for overseeing the inspection process and ensuring all regulatory requirements are met. The Quality Assurance (QA) Manager is responsible for ensuring internal audits and compliance readiness.
5. Procedure
5.1. Pre-Inspection Preparation
- Maintain an updated list of all applicable regulations and guidelines relevant to aerosol manufacturing.
- Ensure that all GMP documentation, including SOPs, batch manufacturing records (BMRs), and validation reports, is up-to-date and readily available.
- Conduct regular internal audits to identify and correct compliance gaps.
- Organize a pre-inspection meeting with key personnel to review the inspection agenda and responsibilities.
- Prepare a designated Inspection Room with access to necessary documents and communication tools.
- Verify that all employees are aware of their roles during an inspection.
5.2. Managing the Inspection
- Welcome the inspectors and provide an overview of the facility.
- Assign a designated host from the Regulatory Affairs Team to accompany the inspectors.
- Provide requested documents promptly and ensure all responses are clear and concise.
- Maintain a log of all questions and requests made by the inspectors (Annexure-1).
- Ensure that employees answer questions honestly and within their scope of expertise.
5.3. Conducting Plant Walkthroughs
- Ensure the facility is clean, well-maintained, and compliant with GMP standards before the inspection.
- Verify that equipment logs, calibration records, and cleaning records are updated.
- Demonstrate compliance with safety protocols, waste disposal procedures, and cross-contamination prevention measures.
- Address any observations made by the inspectors in real-time, if possible.
5.4. Post-Inspection Activities
- Hold a closing meeting to discuss preliminary findings.
- Document all observations and recommendations in the Inspection Summary Report (Annexure-2).
- Develop a Corrective and Preventive Action (CAPA) plan (Annexure-3) to address any deficiencies identified during the inspection.
- Submit required responses to the regulatory authority within the stipulated timeframe.
- Conduct follow-up training and process improvements to ensure continued compliance.
6. Abbreviations
- GMP: Good Manufacturing Practice
- QA: Quality Assurance
- SOP: Standard Operating Procedure
- BMR: Batch Manufacturing Record
- CAPA: Corrective and Preventive Action
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
7. Documents
- Inspection Log (Annexure-1)
- Inspection Summary Report (Annexure-2)
- CAPA Plan (Annexure-3)
8. References
- Good Manufacturing Practice (GMP) Guidelines
- FDA Inspection Guide
- ISO 9001 – Quality Management Systems
- EU GMP Guidelines
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | |||
| Department |
11. Annexures
Annexure-1: Inspection Log
| Inspection Date | Inspector Name | Agency | Key Observations | Action Required |
|---|---|---|---|---|
| 06/02/2025 | John Smith | FDA | Batch record discrepancy | CAPA initiated |
Annexure-2: Inspection Summary Report
| Observation ID | Category | Description | Risk Level | Action Plan |
|---|---|---|---|---|
| OBS-001 | GMP Compliance | Equipment logs incomplete | Medium | Training scheduled |
Annexure-3: CAPA Plan
| CAPA ID | Description | Responsible Person | Implementation Date | Status |
|---|---|---|---|---|
| CAPA-002 | Update SOP for log maintenance | QA Manager | 15/02/2025 | Ongoing |
12. Revision History:
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 01/01/2024 | V 1.0 | Initial Release | First Issue | Anjali Sharma |
| 01/01/2025 | V 2.0 | Updated compliance requirements | GMP and FDA Compliance | Anjali Sharma |